OUST has now printed its June 17 earnings and the market's verdict arrived swiftly: the stock fell 5.4% on the day to $42.73, reversing part of the 11% weekly gain that had carried it back above the May 26 insider sale prices just 24 hours earlier.
The insider pattern that dominated the pre-earnings narrative remains the sharpest lens for reading what happened. On June 12 — five days before the print — the entire executive suite sold simultaneously: CEO Charles Pacala collected roughly $1.2 million, CFO Kenneth Gianella pocketed $2.1 million, Founder and CTO Mark Frichtl added another $715,000 on top of the $12 million he had already extracted on May 26, and the COO, General Counsel, and another C-level officer each trimmed as well. All trades cleared at $38.82. The stock ran to $45.18 on Monday, then closed Tuesday at $42.73 — still above where most of them sold, but the post-print pullback has begun to close that gap. Over 90 days, net insider activity works out to roughly 766,000 shares and $29 million in aggregate value, a number inflated by option-related grants, but the directional message from the June 12 cluster was unambiguous.
Short positioning tells a different story, and it is the more constructive one. Short interest has declined 9% on the week and nearly 14% over the past month, landing at 8.7% of free float — still a meaningful level for a small-cap LiDAR name, but the trend is firmly lower from the 10%-plus readings of late May. The borrow market is relaxed: availability runs at 324%, comfortably above even the tightest level recorded over the past year at 146%, and the cost to borrow is negligible at 0.33%. The ORTEX short score has eased from 56 in early June to 51.7 today. Shorts were not pressing into this print — they spent the rally covering, and there is no sign of forced activity in the lending data. Options are only mildly more cautious than usual. The put/call ratio is 0.47, a little above its 20-day average of 0.41, with a z-score just above one — elevated relative to the recent run but nowhere near the defensive extremes the stock has seen before.
The Street leans constructive, though the analyst picture is mixed in its details. Rosenblatt lifted its target from $40 to $53 on May 27 — the most aggressive recent move — while a new coverage initiation from Amerx added another Buy at $43. Against that, Cantor Fitzgerald downgraded to Neutral on May 7, the day after the prior earnings print landed. The consensus remains Buy with a mean target around $47, implying only modest upside from the current $42.73 close. The bull case rests on the 4QF25 revenue surge to $62.2M and $177M in bookings — though bulls acknowledge the one-time royalty that inflated that margin print. Bears point to rising competition from larger LiDAR players, geographic concentration, and a balance sheet still burning cash: the EV/EBITDA multiple is deeply negative at -129x and the price-to-book has expanded to over 10x on the back of the rally. Factor scores highlight the bifurcated picture — EPS surprise ranks in the 95th percentile, analyst recommendation differential at the 94th, but the short score rank sits at just the 15th percentile, reflecting the still-elevated short interest relative to peers.
Among correlated names, the post-earnings session was broadly weak. AEVA fell 10.9% on the day — the sharpest single-day drop in the peer group — while VSH and VPG each shed around 5%. INVZ was the only peer down meaningfully on the week at -8.8%. OUST's 11% weekly gain and 23% monthly return still stand well above most of the group, despite Tuesday's reversal.
The next scheduled event is August 13. Between now and then, the question is whether the June 17 print's substance — stripped of the one-time royalty — supports the multiple expansion that drove the past month's rally, and whether executive selling pressure re-emerges if the stock stabilises above $40.
See the live data behind this article on ORTEX.
Open OUST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
